Table 4. Multivariate analysis for pCR predictive parameters.
Variable | pCR (n) | Non-pCR (n) | P value | Hazard ratio | 95% CI |
---|---|---|---|---|---|
Menstrual status | |||||
Premenopause | 13 | 30 | 0.191 | 2.391 | 0.647–8.831 |
Postmenopause | 17 | 28 | |||
Age | |||||
≤ 35 years | 4 | 9 | 0.131 | 4.168 | 0.655–26.532 |
> 35years | 26 | 49 | |||
BMI | |||||
≤ 25 | 20 | 34 | 0.432 | 1.558 | 0.516–4.708 |
> 25 | 10 | 24 | |||
Laterality | |||||
Left | 14 | 36 | 0.121 | 2.035 | 0.830–4.993 |
Right | 16 | 22 | |||
Family history | |||||
Yes | 3 | 3 | 0.086 | 0.441 | 0.173–1.123 |
No | 27 | 55 | |||
Cycles | |||||
< 4 | 4 | 8 | 0.897 | 1.102 | 0.253–4.806 |
≥ 4 | 26 | 50 | |||
HR status | |||||
Negative | 22 | 22 | < 0.001 | 5.587 | 2.257–13.889 |
Positive | 8 | 36 | |||
Ki-67 | |||||
High (> 30%) | 19 | 20 | 0.003 | 4.130 | 1.607–10.610 |
Low (≤ 30%) | 11 | 38 | |||
T stage | |||||
T1–2 | 24 | 49 | 0.780 | 0.850 | 0.272–2.659 |
T3–4 | 6 | 9 |
pCR: pathologic complete response; BMI: body mass index; HR: hormone receptor; T: tumor; CI: confidence interval.